Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer (Q37095310)
Jump to navigation
Jump to search
scientific article published on 13 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer |
scientific article published on 13 September 2012 |
Statements
1 reference
Cost-effectiveness of the 21-gene recurrence score assay in the context of multifactorial decision making to guide chemotherapy for early-stage breast cancer (English)
1 reference
Shelby D Reed
1 reference
Michaela A Dinan
1 reference
Kevin A Schulman
1 reference
Gary H Lyman
1 reference
13 September 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference